FDA Inspection 801001 - Respa Pharmaceuticals Inc. - October 04, 2012

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Respa Pharmaceuticals Inc., with an inspection on October 4, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Respa Pharmaceuticals Inc.
Inspection Date: October 4, 2012
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 72083ff8-c4da-42a5-a9fc-9ac800c23b1c

Violation Codes2

21 CFR 211.198(a)21 CFR 211.22(d)

Full citation text and observation details available on the Dashboard.